Vanadium oxoions have been shown to elicit a wide range of effects in biological systems, including an increase in the quantity of phosphorylated proteins. This response has been attributed to the inhibition of protein phosphatases, the indirect activation of protein kinases via stimulation of enzymes at early steps in signal transduction pathways and/or the direct activation of protein kinases. We have evaluated the latter possibility by exploring the effects of vanadate, decavanadate and vanadyl cation species on the activity of the cAMP-dependent protein kinase (PKA), a serine/threonine kinase. Vanadate, in the form of monomer, dimer, tetramer and pentamer species, neither inhibits nor activates PKA. In marked contrast, decavanadate is a competitive inhibitor (Ki = 1.8ŷ0.1 mM) of kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly), a peptide-based substrate. This inhibition pattern is especially surprising, since the negatively charged decavanadate would not be predicted to bind to the region of the active site of the enzyme that accommodates the positively charged kemptide substrate. Our studies suggest that decavanadate can associate with kemptide in solution, which would prevent kemptide from interacting with the enzyme. Vanadium(IV) also inhibits the PKA-catalysed phosphorylation of kemptide, but with an IC50 of 366ŷ10 ƁM. However, in this case V4+ appears to bind to the Mg2+-binding site, since it can substitute for Mg2+. In the absence of Mg2+, the optimal concentration of vanadium(IV) for the PKA-catalysed phosphorylation of kemptide is 100 ƁM, with concentrations above 100 ƁM being markedly inhibitory. However, even at the optimal 100 ƁM V4+ concentration, the Vmax and Km values (for kemptide) are significantly less favourable than those obtained in the presence of 100 ƁM Mg2+. In summary, we have found that oxovanadium ions can directly alter the activity of the serine/threonine-specific PKA.
Skip Nav Destination
Article navigation
January 1997
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Research Article|
January 15 1997
Vanadium oxoanions and cAMP-dependent protein kinase: an anti-substrate inhibitor
Scott PLUSKEY;
Scott PLUSKEY
*Department of Biochemistry, The Albert Einstein College of Medicine, Yeshiva University, 1300 Morris Park Ave., Bronx, NY 10461, U.S.A.
Search for other works by this author on:
Mohammad MAHROOF-TAHIR;
Mohammad MAHROOF-TAHIR
†Department of Chemistry, Colorado State University, Fort Collins, CO 80523, U.S.A.
Search for other works by this author on:
Debbie C. CRANS;
Debbie C. CRANS
‡
†Department of Chemistry, Colorado State University, Fort Collins, CO 80523, U.S.A.
‡To whom correspondence should be addressed.
Search for other works by this author on:
David S. LAWRENCE
David S. LAWRENCE
‡
*Department of Biochemistry, The Albert Einstein College of Medicine, Yeshiva University, 1300 Morris Park Ave., Bronx, NY 10461, U.S.A.
‡To whom correspondence should be addressed.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 13 1996
Revision Received:
August 27 1996
Accepted:
September 06 1996
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 1997
1997
Biochem J (1997) 321 (2): 333–339.
Article history
Received:
May 13 1996
Revision Received:
August 27 1996
Accepted:
September 06 1996
Citation
Scott PLUSKEY, Mohammad MAHROOF-TAHIR, Debbie C. CRANS, David S. LAWRENCE; Vanadium oxoanions and cAMP-dependent protein kinase: an anti-substrate inhibitor. Biochem J 15 January 1997; 321 (2): 333–339. doi: https://doi.org/10.1042/bj3210333
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.